Peter Ulvskjold was named CEO of Denmark-based AI software developer Radiobotics, effective October 1.
Ulvskjold has more than 20 years of pharma and medtech experience, working internationally in general management, commercialization, strategic execution, and globalization in various senior management roles at Novo Nordisk, ConvaTec, and most recently as CEO for the Swedish biotech company Atlas Antibodies, Radiobotics said.
Peter Ulvskjold
Radiobotics develops AI technology for x-ray analysis, with a focus on products for musculoskeletal radiology.
